Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2012
05/23/2012EP2454239A1 Substituted triazole and imidazole derivatives as gamma secretase modulators
05/23/2012EP2228370B1 N-{1-[3-(2-ethoxy-5-(4-ethylpiperazinyl)benzenesulfonyl)-4,5-dihydro-5-oxo-1,2,4-triazin-6-yl]ethyl}butyramide, the preparation method and use thereof
05/23/2012CN1997645B Immunomodulating oxopyrrazolocinnolines as CD80 inhibitors
05/23/2012CN102471602A Materials for organic electroluminescence devices
05/23/2012CN102471346A Jak的三环抑制剂 Jak tricyclic inhibitors
05/23/2012CN102471345A 激酶的吡咯并吡嗪抑制剂 Kinase inhibitors pyrrolopyrazine
05/23/2012CN102471344A 7-[(3r)-3-氨基-1-氧代-4-(2,4,5-三氟苯基)丁基]-5,6,7,8-四氢-3-(三氟甲基)-1,2,4-三唑并[4,3-a]吡嗪的结晶化合物 7 - [(3r) -3- amino-1-oxo-4- (2,4,5-trifluorophenyl) butyl] -5,6,7,8-tetrahydro-3- (trifluoromethyl methyl) -1,2,4-triazolo [4,3-a] pyrazine The crystalline compound
05/23/2012CN102471343A 作为自分泌运动因子抑制剂的杂环化合物 Heterocyclic compounds as inhibitors of autocrine motility factor
05/23/2012CN102471342A 用作PKC-θ抑制剂的4取代的吡唑并吡啶类 As a 4-substituted pyrazolo pyridine inhibitors PKC-θ
05/23/2012CN102471341A Compounds and compositions for the treatment of parasitic diseases
05/23/2012CN102471338A 新的氮杂杂环化合物 The new aza-heterocyclic compounds
05/23/2012CN102471334A 促代谢型谷氨酸受体调节剂 Metabotropic glutamate receptor modulators
05/23/2012CN102471327A Inhibitors of flaviviridae viruses
05/23/2012CN102471317A 用于治疗肿瘤和炎性疾病的氨基吡啶衍生物 For the treatment of cancer and inflammatory diseases aminopyridine derivative
05/23/2012CN102471293A Oxazine derivatives and their use as BACE inhibitors for the treatment of neurological disorders
05/23/2012CN102471292A 取代的3-氨基-5-氧代-4,5-二氢-[1,2,4]三氮烯的方法 Substituted 3-amino-5-oxo-4,5-dihydro - [1,2,4] triazene method
05/23/2012CN102470136A Plk 抑制剂的盐类 Plk inhibitors salts
05/23/2012CN102464667A 一类五元杂环并嘧啶类化合物及其制备方法和用途 A class of five-membered heterocyclic pyrimidine compounds and their preparation and use
05/23/2012CN102464662A 乌洛托品母液脱色过滤系统 Methenamine liquor decolorization filtration system
05/23/2012CN102464661A 一种5,6,7,8-四氢-咪唑并[1,5-a]吡嗪-1-羧酸乙酯的制备方法 One kind of 5,6,7,8-tetrahydro - imidazo [1,5-a] pyrazine-1-carboxylic acid ethyl ester Method
05/23/2012CN102464660A 6-(4-氯苯基)-2,2-二甲基-7-苯基-2,3-二氢基-吡咯哩嗪-5-乙酸硝酸丁酯晶体及其制备方法和应用 6- (4-chlorophenyl) -2,2-dimethyl-7-phenyl-2,3-dihydro-based - pyrrole-5-mile butyl acetate nitrate crystal and preparation method and application
05/23/2012CN102464659A 利可瑞特化合物结晶形态、其制备方法及用途 Lee can Reiter crystalline form compounds, their preparation and use
05/23/2012CN102068436B Dihydroporphin photosensitizer and preparation and application thereof
05/23/2012CN101870700B Method for synthesizing Indiplon
05/23/2012CN101851241B Anti-tumor compound and preparation method and application thereof
05/23/2012CN101768368B Weather-resistant black dye and preparation method and application thereof
05/23/2012CN101735222B Pyrrole-nitrogen heterocyclic tropone compound and application thereof as protein-tyrosine-phosphatase 1 B inhibitor
05/23/2012CN101676287B 6-(substituted phenoxy)-tetrazolo[5,1-a] phthalazine derivatives as antuepileptics and their pharmaceutically acceptable salts
05/23/2012CN101628888B Inhibitors of cytosolic phospholipase a2
05/23/2012CN101613353B Synthesis method of tetra (4-dimethylaminophenyl) porphyrin and derivatives thereof
05/23/2012CN101160314B Small molecule inhibitors of mdm2 and the uses thereof
05/22/2012US8183412 Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
05/22/2012US8183373 Solid state forms of sitagliptin salts
05/22/2012US8183364 Substituted porphyrins
05/22/2012US8183277 Inhibitors of HCV replication of formula (I)** Image-1whereinW is a heterocycle of formula** Image-2and the remaining variables are as defined in the specification.
05/22/2012US8183273 Bicyclic compound, production and use thereof
05/22/2012US8183250 Potent PARP inhibitors
05/22/2012US8183248 Substituted pyrrolo[2,3-d]pyrimidines and compositions as protein kinase inhibitors
05/22/2012US8183247 Boron compounds useful in BNCT
05/22/2012US8183241 2-oxo-1-pyrrolidine derivatives
05/22/2012US8183238 Bicyclic and tricyclic compounds as KAT II inhibitors
05/22/2012US8183019 (3R,4R)-3-hydroxy-4-hydroxymethylpyrrolidine or (3S,4S)-3-hydroxy-4-hydroxymethylpyrrolidine; enzyme-catalysed enantioselective hydrolysis of a racemic 3,4-trans-disubstituted pyrrolidinone; for purine nucleoside phosphorylase (PNP) inhibitors
05/22/2012US8182695 Bridged macrocyclic module compositions
05/22/2012CA2681136C Heterocyclic compounds and their uses
05/22/2012CA2635482C Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
05/22/2012CA2508069C Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
05/18/2012WO2012065139A2 Entpd5 inhibitors
05/18/2012WO2012065022A2 Spiro-oxindole mdm2 antagonists
05/18/2012WO2012064973A2 Heterocyclic compounds and uses thereof
05/18/2012WO2012062748A1 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/18/2012WO2012062745A1 Alkoxy-substituted 2,3-dihydroimidazo[1,2-c]quinazolines
05/18/2012WO2012062743A1 Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-c]quinolines
05/18/2012WO2012038980A3 Fused tricyclic compounds as adenosine receptor antagonist
05/18/2012WO2012012809A3 APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
05/18/2012CA2817585A1 Spiro-oxindole mdm2 antagonists
05/18/2012CA2817577A1 Heterocyclic compounds and uses thereof
05/18/2012CA2817317A1 Aminoalcohol substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/18/2012CA2817312A1 Alkoxy-substituted 2,3-dihydroimidazo[1,2-c]quinazolines
05/18/2012CA2817287A1 Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-c]quinolines
05/18/2012CA2816769A1 Substituted heteroaromatic carboxamide and urea derivatives as vanilloid receptor ligands
05/17/2012US20120123118 Process For The Preparation Of Nitroorotic Acid
05/17/2012US20120123113 Di-substituted pyridinum polymers and synthesis thereof
05/17/2012US20120122947 Spiro-oxindole mdm2 antagonists
05/17/2012US20120122924 Nampt inhibitors
05/17/2012US20120122898 Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7h-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
05/17/2012US20120122895 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122892 Chemical compounds
05/17/2012US20120122888 Potassium Channel Modulators
05/17/2012US20120122879 Compounds useful as protein kinase inhibitors
05/17/2012US20120122875 Salts of Methyl (R)-7-[3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyryl]-3-Trifluoromethyl-5,6,7,8-Tetrahydro-Imidazo[1,5-A]Pyrazine-1-Carboxylate
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists
05/17/2012US20120122838 Heterocyclic compounds and uses thereof
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122833 Deuterium-enriched meropenem
05/17/2012US20120122819 Guanine riboswitch binding compounds and their use as antibiotics
05/17/2012US20120122680 Mesoionic pesticides
05/17/2012US20120122679 Mesoionic pesticides
05/17/2012US20120121727 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases
05/17/2012US20120121540 Certain Nitrogen Containing Bicyclic Chemical Entities For Treating Viral Infections
05/17/2012US20120119198 Fullerene derivatives
05/16/2012EP2451815A1 INDUCTION OF alpha-HELIX CONFORMATIONS IN PROTEINS AND PEPTIDES
05/16/2012EP2451814A2 Fused imidazoles and compositions comprising them for the treatment of parasitic diseases, such as e.g. malaria
05/16/2012EP2451813A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors
05/16/2012EP2451812A1 SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS
05/16/2012EP2451811A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
05/16/2012EP2451802A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
05/16/2012EP2451792A2 Process for substituted 3-amino-5-oxo-4,5-dihydro-[1,2,4]triazines
05/16/2012EP2451285A1 Platelet-activating factor receptor antagonists
05/16/2012EP2313413B1 Pyrazolo [1, 5-a] pyrimidine derivatives
05/16/2012CN102459411A New process and new compounds
05/16/2012CN102459273A 用于研究、成像以及治疗疼痛的方法和组合物 For research, imaging, and methods and compositions for the treatment of pain
05/16/2012CN102459272A 对P110δ具有选择性的为PI3K抑制剂的二环嘧啶化合物和使用方法 Selective for P110δ bicyclic pyrimidine compounds and methods of use for the PI3K inhibitor
05/16/2012CN102459271A 回折模拟物的新化合物及其制备方法和用途 Fold back the new compound mimics its preparation method and use
05/16/2012CN102459270A Janus激酶3的哌啶抑制剂 Janus kinase 3 inhibitor piperidine
05/16/2012CN102459265A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459264A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459249A 作为PI3K/mTOR抑制剂的苯并氧氮杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxazepine cycloheptatriene and their use and manufacturing method
05/16/2012CN102459248A 作为PI3K/mTOR抑制剂的苯并氧杂环庚三烯以及它们使用与制造方法 As the PI3K / mTOR inhibitor benzoxepin-triene and their method of use and manufacture
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 573